China Deal Monitor: YuanBio Venture Capital invests in PushKang and more updates

China Deal Monitor: YuanBio Venture Capital invests in PushKang and more updates

In-vitro diagnostic (IVD) solutions player Zhejiang Pushikang Biotechnology Co., Ltd. has pocketed ‘millions of dollars’ in a Series B round of financing led by YuanBio Venture Capital (also known as bioVenture), according to an announcement on Wednesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter